The Food and Drug Administration is introducing sweeping reforms to stop misleading pharmaceutical advertisements.
As part of the initiative, the FDA sent thousands of letters warning pharmaceutical companies to remove misleading ads and issuing approximately 100 cease-and-desist letters to companies with deceptive ads.
The FDA is also taking steps to close the “adequate provision” loophole created in 1997, which they claim drug companies have used to conceal critical safety risks in broadcast and digital ads, fueling inappropriate drug use and eroding public trust.
Read more at Newsmax© 2025 Newsmax. All rights reserved.